Investigational drug for genetic form of ALS improves disease’s molecular signs
An international phase 3 clinical trial for a drug developed to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS) showed that it reduced molecular signs of the fatal disease, but at six months did not improve motor control and muscle strength, according to Washington University School of Medicine researchers.
WashU researchers observe cancer-like nucleoli in healthy cells
A discovery in the lab of Amit Pathak at the McKelvey School of Engineering connects mechanobiology to nuclear condensates in healthy cells.
Siteman, University of Missouri to collaborate on cancer research, with aim to improve care
Siteman Cancer Center and the University of Missouri will collaborate on cancer research, with the aim to improve care throughout Missouri.
Gordon honored by National Academy of Medicine
Washington University School of Medicine’s Jeffrey Gordon, MD, has received the inaugural David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine from the National Academy of Medicine. Gordon is regarded as the father of the field of microbiome research.
Washington University Orthopedics teams up with St. Louis CITY Soccer Club
St. Louis CITY Soccer Club has chosen physicians with Washington University Orthopedics as the club’s official team doctors and BJC HealthCare as medical services provider.
Sugarcane fires associated with mortality rates in South Florida
Research from a multi-institutional team, including Randall Martin at the McKelvey School of Engineering, estimated sugarcane fires in South Florida produce harmful emissions in quantities on par with vehicles — and play a role in the region’s mortality rates.
School of Medicine joins NIH initiative to expand use of AI in biomedical research
Washington University School of Medicine is joining the National Institutes of Health (NIH)’s Bridge2AI program, an estimated $130 million initiative. One project aims to develop a framework for using artificial intelligence to diagnose disease based on the sound of patients’ voices.
Personalized prediction of depression treatment outcomes with wearables
Using Fitbits and a novel machine learning model, a multi-institutional team led by Washington University’s Chenyang Lu is ushering in the next step in personalization for treatment of depression.
Ssewamala awarded $3.2M to study strategies for HIV treatments among Ugandan youth
Fred Ssewamala, the William E. Gordon Distinguished Professor at the Brown School, received a five-year $3.2 million grant from the National Institutes of Health to lead a study on intervention strategies for HIV treatments among Ugandan youth. The study could advance intervention science for HIV care globally.
Problems persist for kids exposed to cannabis in the womb
Research from Ryan Bogdan’s BRAIN Lab in Arts & Sciences finds signs of psychopathology persist into mid-adolescence in kids exposed to cannabis in the womb.
Older Stories